Dr Ailawadhi reported receiving grants from Janssen, Amgen, Cellectar, Ascentage, and AstraZeneca and personal fees from Takeda, BMS, GSK, and Beigene outside the submitted work. Dr Manochakian reported receiving personal fees from AstraZeneca, Novocure, Guardant Health, and Takeda outside the submitted work. Statistical analysis: Chen, Cochuyt, Hodge, Ailawadhi.Īdministrative, technical, or material support: Zhou, Shi, Chen.Ĭonflict of Interest Disclosures: Ms Chen reported that her spouse is employed by Gilead Sciences and that she holds stocks in Eli Lilly. Drs Zhou and Shi contributed equally to this work.Ĭoncept and design: Zhou, Shi, Chen, Manochakian, Ailawadhi, Lou.Īcquisition, analysis, or interpretation of data: Shi, Chen, Cochuyt, Hodge, Manochakian, Zhao, Ailawadhi.ĭrafting of the manuscript: Zhou, Chen, Manochakian, Ailawadhi.Ĭritical revision of the manuscript for important intellectual content: Shi, Chen, Cochuyt, Hodge, Manochakian, Zhao, Ailawadhi, Lou.
Corresponding Author: Yanyan Lou, MD, PhD, Division of Hematology and Medical Oncology, Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL 32224 ( Contributions: Dr Lou had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
0 kommentar(er)
